These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 7018514)
1. Effect of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients. -I) In vitro study. Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T Boll Soc Ital Biol Sper; 1980 Feb; 56(4):308-11. PubMed ID: 7018514 [No Abstract] [Full Text] [Related]
2. Effects of thymopoietin pentapeptide on low reversible E-rosette forming cells of rheumatoid arthritis patients.-II) In vivo study. Auteri A; Laghi Pasini F; Pasqui AL; Bilenchi R; Di Perri T Boll Soc Ital Biol Sper; 1980 Feb; 56(4):312-5. PubMed ID: 7018515 [No Abstract] [Full Text] [Related]
3. Pharmacological induced depression of E-rosette forming cells (RFC) of normal healthy subjects. Restoration by levamisole and thymopoietin pentapeptide. Laghi Pasini F; Auteri A; Ceccatelli L; Di Perri T Boll Soc Ital Biol Sper; 1980 Feb; 56(4):316-22. PubMed ID: 7018516 [TBL] [Abstract][Full Text] [Related]
4. Restoration of the impaired lymphocyte stimulation in old people by thymopoietin pentapeptide. Verhaegen H; De Cock W; De Cree J; Goldstein G J Clin Lab Immunol; 1981 Sep; 6(2):103-5. PubMed ID: 7026790 [TBL] [Abstract][Full Text] [Related]
5. Immunokinetics of a single dose of thymopoietin pentapeptide. Di Perri T; Laghi Pasini F; Auteri A J Immunopharmacol; 1980; 2(4):567-72. PubMed ID: 7009760 [TBL] [Abstract][Full Text] [Related]
6. Effects of synthetic thymopoietin II fragments on E-rosette forming cells of a rheumatoid arthritis patient. Abiko T; Onodera I; Sekino H Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2322-9. PubMed ID: 7318039 [No Abstract] [Full Text] [Related]
7. Induction and augmentation of mitogen-induced immune interferon production in human lymphocytes by a synthetic thymopoietin pentapeptide. Diezel W; Waschke SR; Forner K Biomed Biochim Acta; 1984; 43(6):K9-12. PubMed ID: 6435610 [No Abstract] [Full Text] [Related]
8. Comparison of the in vitro effects of thymopoietin pentapeptide and levamisole on peripheral E-rosette forming cells. Verhaegen H; De Cock W; De Cree J; Goldstein G Thymus; 1980 Jan; 1(4-5):195-204. PubMed ID: 7445020 [TBL] [Abstract][Full Text] [Related]
9. Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division. Denes L; Szende B; Ember J; Major J; Szporny L; Hajos G; Nyeki O; Schon I; Lapis K; Kisfaludy L Immunopharmacol Immunotoxicol; 1987; 9(1):1-18. PubMed ID: 3330094 [TBL] [Abstract][Full Text] [Related]
10. The effect of thymopoietin II fragments and their analogs on E-rosette forming cells in the uremic state. Abiko T; Onodera I; Sekino H Chem Pharm Bull (Tokyo); 1980 Aug; 28(8):2507-11. PubMed ID: 7428129 [No Abstract] [Full Text] [Related]
12. Effects of thymopoietin pentapeptide (TP-5) on in vitro and in vivo IgE production by atopic dermatitis cell subsets. Cooper KD; Kang K; Hanifin JM Diagn Immunol; 1983; 1(3):211-5. PubMed ID: 6388971 [TBL] [Abstract][Full Text] [Related]
13. Structural requirements for the biological activity of thymopentin analogs. Heavner GA; Audhya T; Kroon D; Goldstein G Arch Biochem Biophys; 1985 Oct; 242(1):248-55. PubMed ID: 2996431 [TBL] [Abstract][Full Text] [Related]
14. Influence of thymic hormones on mitogen-induced interferon production in lymphocytes. II. Enhancement of Con-A-induced immune interferon production by a synthetic thymopoietin pentapeptide. Rentz E; Diezel W; Ehrlich A; Forner K Arch Geschwulstforsch; 1984; 54(2):113-8. PubMed ID: 6329122 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and effects of two peptide fragments of thymopoietin II on E-rosette forming cells in the uremic state. Abiko T; Kumikawa M; Sekino H Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2233-7. PubMed ID: 519816 [No Abstract] [Full Text] [Related]
16. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients. Munno I; Pellegrino NM; Fumo G; Barbieri G; Polimeno G; de Filippis V; Jirillo E Cytobios; 1987; 52(210-211):167-73. PubMed ID: 3123147 [TBL] [Abstract][Full Text] [Related]
17. Thymopoietin pentapeptide (thymopentin, TP-5) in the treatment of rheumatoid arthritis. A compilation of several short- and longterm clinical studies. Veys EM; Mielants H; Verbruggen G; Spiro T; Newdeck E; Power D; Goldstein G J Rheumatol; 1984 Aug; 11(4):462-6. PubMed ID: 6384507 [TBL] [Abstract][Full Text] [Related]
18. [Stimulation of immunogenesis by neurotensin, pentagastrin and thymopentin and ways of its realization]. Belokrylov GA; Molchanova IV; Popova OIa Biull Eksp Biol Med; 1989 Nov; 108(11):584-7. PubMed ID: 2699257 [TBL] [Abstract][Full Text] [Related]
19. Arg-Lys-Asp-Val-Tyr (thymopentin) accelerates the cholinergic-induced inactivation (desensitization) of reconstituted nicotinic receptor. Ochoa EL; Medrano S; de Carlin MC; Dilonardo AM Cell Mol Neurobiol; 1988 Sep; 8(3):325-31. PubMed ID: 3066488 [TBL] [Abstract][Full Text] [Related]
20. The in vitro effect of the thymic factor thymopoietin on a subpopulation of lymphocytes from severely malnourished children. Jackson TM; Zaman SN Clin Exp Immunol; 1980 Mar; 39(3):717-21. PubMed ID: 6769624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]